We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$1.86B
AUM Growth
-$29.3M
Cap. Flow
+$12.7M
Cap. Flow %
0.68%
Top 10 Hldgs %
25.44%
Holding
3,170
New
862
Increased
454
Reduced
544
Closed
1,281

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$241M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.4M
3
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$27.8M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$26.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$26M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$50.9M
2
GLD icon
SPDR Gold Trust
GLD
+$40.5M
3
SLV icon
iShares Silver Trust
SLV
+$19.8M
4
SVXY icon
ProShares Short VIX Short-Term Futures ETF
SVXY
+$15.5M
5
XRT icon
State Street SPDR S&P Retail ETF
XRT
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Healthcare 5.01%
3 Consumer Discretionary 4.9%
4 Financials 4.51%
5 Industrials 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALO
1676
DELISTED
Alio Gold Inc
ALO
$61K ﹤0.01%
31,276
+20,187
+182% +$58.6K
CFRX
1677
DELISTED
ContraFect Corporation
CFRX
$61K ﹤0.01%
47
-38
-45% -$46.9K
ASXC
1678
DELISTED
Asensus Surgical, Inc.
ASXC
$60K ﹤0.01%
2,714
-1,629
-38% -$37.3K
FRTX
1679
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$59K ﹤0.01%
+128
New +$63.6K
SDRL
1680
DELISTED
Seadrill Limited Common Stock
SDRL
$59K ﹤0.01%
1,135
-2,889
-72% -$200K
NWY
1681
DELISTED
New York & Co Inc
NWY
$59K ﹤0.01%
+17,543
New +$52K
CDTX
1682
DELISTED
Cidara Therapeutics
CDTX
$58K ﹤0.01%
+727
New +$99.3K
IPWR icon
1683
Ideal Power
IPWR
$70M
$58K ﹤0.01%
5,076
+3,336
+192% +$41.6K
XELA
1684
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$58K ﹤0.01%
1
-1
-50% -$66.5K
NNA
1685
DELISTED
Navios Maritime Acquisition Corporation
NNA
$58K ﹤0.01%
4,606
+1,852
+67% +$24.4K
IMUC
1686
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$58K ﹤0.01%
231,736
+38,243
+20% +$10.6K
GORO icon
1687
Goldgroup Mining Inc.
GORO
$211M
$57K ﹤0.01%
12,711
-65,870
-84% -$296K
TNXP icon
1688
Tonix Pharmaceuticals
TNXP
$214M
– –
0
– –
WPRT
1689
Westport Fuel Systems
WPRT
$32.7M
$57K ﹤0.01%
+2,599
New +$78.5K
ENZ
1690
DELISTED
Enzo Biochem, Inc.
ENZ
$57K ﹤0.01%
+10,321
New +$72.7K
OCGN icon
1691
Ocugen
OCGN
$458M
$56K ﹤0.01%
339
-720
-68% -$115K
RGLS
1692
DELISTED
Regulus Therapeutics
RGLS
$56K ﹤0.01%
+655
New +$87.6K
GNW icon
1693
Genworth Financial
GNW
$3.77B
$55K ﹤0.01%
+19,362
New +$58.2K
CTHR
1694
DELISTED
Charles & Colvard Ltd
CTHR
$55K ﹤0.01%
+4,050
New +$55.8K
BETS
1695
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
– –
0
– –
BCRX icon
1696
BioCryst Pharmaceuticals
BCRX
$2.51B
$54K ﹤0.01%
+11,374
New +$58.4K
MFIN icon
1697
Medallion Financial
MFIN
$262M
$54K ﹤0.01%
+11,607
New +$53.2K
ACGN
1698
DELISTED
Aceragen Inc
ACGN
$54K ﹤0.01%
215
+56
+35% +$15.4K
ADOM
1699
DELISTED
ADOMANI Inc
ADOM
$54K ﹤0.01%
+45,759
New +$81.8K
TAHO
1700
DELISTED
Tahoe Resources Inc
TAHO
$54K ﹤0.01%
11,428
-15,106
-57% -$68.9K
66 67
68
69 70

Similar funds

FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.2B AUM 32.2% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Virtu Financial's Q1 2018 Portfolio in Review

As of Q1 2018, Virtu Financial held 3,170 positions worth $1.86B, down 1.5% from $1.89B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Virtu Financial's Q1 2018 filing shows 862 new, 454 increased, 544 reduced and 1,281 closed positions. Its largest new stake was iShares Systematic Bond ETF: 201,793 shares worth $19.7M. The largest sale was Berkshire Hathaway Class A, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 5.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Virtu Financial's largest Q1 2018 buy was iShares Systematic Bond ETF: 201,793 shares worth $19.7M.
  • Virtu Financial added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $241M increase.
  • Virtu Financial's biggest Q1 2018 reduction was Berkshire Hathaway Class A, cutting an estimated $50.9M.
  • Virtu Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q1 2018, selling an estimated $15.5M.
  • Virtu Financial's ten largest holdings make up 25% of its $1.86B portfolio in Q1 2018.
  • Virtu Financial opened 862 new positions and closed 1,281 in Q1 2018.
  • Virtu Financial's portfolio value fell 1.5% quarter-over-quarter to $1.86B.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.